Mark Bilodeau Email & Phone Number
@tarveda.com
3 phones found area 617
LinkedIn matched
Who is Mark Bilodeau? Overview
A concise factual answer block for searchers comparing this professional profile.
Mark Bilodeau is listed as Chief Scientific Officer, Kestrel Therapeutics at Kestrel Therapeutics, based in Watertown, Massachusetts, United States. AeroLeads shows a work email signal at tarveda.com, phone signal with area code 617, and a matched LinkedIn profile for Mark Bilodeau.
Mark Bilodeau previously worked as Chief Scientific Officer at Kestrel Therapeutics and Chief Scientific Officer at Tarveda Therapeutics. Mark Bilodeau holds Doctor Of Philosophy (Ph.D.), Organic Chemistry from Harvard University.
Email format at Kestrel Therapeutics
This section adds company-level context without repeating Mark Bilodeau's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Bilodeau. Compare company email patterns before reaching out.
About Mark Bilodeau
Mark Bilodeau is a Chief Scientific Officer, Kestrel Therapeutics at Kestrel Therapeutics. He possess expertise in drug discovery, medicinal chemistry, oncology, neuroscience, biotechnology and 3 more skills.
Listed skills include Drug Discovery, Medicinal Chemistry, Oncology, Neuroscience, and 4 others.
Mark Bilodeau's current company
Company context helps verify the profile and gives searchers a useful next step.
Mark Bilodeau work experience
A career timeline built from the work history available for this profile.
Chief Scientific Officer
Executive Vice President, Drug Discovery
Senior Director
Managed up to 60 people in four functions supporting the Neuroscience franchise. Leader of an Exploratory Chemistry group Managed the Chemistry Modeling and Informatics group, the Automated Synthesis and Purification group and the Spectroscopy and Analytical group. - Led hit identification, target validation and lead identification on over 30 therapeutic targets of interest. - Advanced several high-priority programs into lead optimization- Led a team to develop the company’s fragment screening strategy.
Post-Doctoral Fellow
Explored the application of glycal methodology to the synthesis of complex polysaccharides. Achieved the total synthesis and proof of structure of a human breast tumor antigen (Globo-H).
Mark Bilodeau education
Doctor Of Philosophy (Ph.D.), Organic Chemistry
Bachelor’S Degree, Chemistry
Frequently asked questions about Mark Bilodeau
Quick answers generated from the profile data available on this page.
What company does Mark Bilodeau work for?
Mark Bilodeau works for Kestrel Therapeutics.
What is Mark Bilodeau's role at Kestrel Therapeutics?
Mark Bilodeau is listed as Chief Scientific Officer, Kestrel Therapeutics at Kestrel Therapeutics.
What is Mark Bilodeau's email address?
AeroLeads has found 1 work email signal at @tarveda.com for Mark Bilodeau at Kestrel Therapeutics.
What is Mark Bilodeau's phone number?
AeroLeads has found 3 phone signal(s) with area code 617 for Mark Bilodeau at Kestrel Therapeutics.
Where is Mark Bilodeau based?
Mark Bilodeau is based in Watertown, Massachusetts, United States while working with Kestrel Therapeutics.
What companies has Mark Bilodeau worked for?
Mark Bilodeau has worked for Kestrel Therapeutics, Tarveda Therapeutics, Merck, and Memorial Sloan-Kettering Cancer Center.
How can I contact Mark Bilodeau?
You can use AeroLeads to view verified contact signals for Mark Bilodeau at Kestrel Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Mark Bilodeau attend?
Mark Bilodeau holds Doctor Of Philosophy (Ph.D.), Organic Chemistry from Harvard University.
What skills is Mark Bilodeau known for?
Mark Bilodeau is listed with skills including Drug Discovery, Medicinal Chemistry, Oncology, Neuroscience, Biotechnology, Leadership, Adme, and Intellectual Property.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial